Description
Headon injection (Somatropin) 4 IU
Headon injection contains somatropin, a recombinant form of human growth hormone. It is used as hormone replacement therapy in patients with confirmed growth hormone deficiency and related approved endocrine indications, depending on the local product label.
Active Ingredient and Medicine Class
Somatropin is a recombinant human growth hormone and a peptide hormone medicine. It acts as a replacement for endogenous growth hormone when the body does not produce enough of it.
Established Medical Uses
Somatropin is established in the treatment of growth hormone deficiency in children and adults. Regulatory labels for somatropin products also include several other indications in some countries, such as selected childhood growth disorders and certain conditions associated with short stature or severe weight loss, but the exact approved uses depend on the specific product and jurisdiction.
How It Works
Somatropin binds to the growth hormone receptor and activates signalling pathways that increase insulin-like growth factor-1 (IGF-1) production. This helps support linear growth in children and influences body composition and metabolism in adults with deficiency. Human and review literature describe both direct growth hormone effects and indirect IGF-1-mediated effects.
Important Safety Information
Somatropin is generally contraindicated in patients with active malignancy and in acute critical illness. Product labels also warn against use in patients with hypersensitivity to somatropin or excipients, and in children with closed epiphyses. Somatropin should be used cautiously in patients with a history of tumors because growth hormone therapy may be associated with tumour progression or recurrence risk concerns in some settings. It can also affect glucose metabolism, so caution is needed in patients with diabetes or impaired glucose tolerance. Important interactions include insulin and other glucose-lowering medicines, glucocorticoids, and oral oestrogens, which may alter response or require closer monitoring.
Possible Side Effects
Reported adverse effects of somatropin include injection-site reactions, fluid retention, joint or muscle pain, headache, and changes in glucose control. More serious reactions described in prescribing information include intracranial hypertension, slipped capital femoral epiphysis in children, worsening scoliosis during rapid growth, pancreatitis, hypersensitivity reactions, and worsening of underlying endocrine disorders such as hypothyroidism or adrenal insufficiency.
Scientific Evidence
Peer-reviewed reviews show that growth hormone replacement in children with growth hormone deficiency supports linear growth, and in adults with deficiency it can improve body composition, muscle strength, bone measures, and quality of life. Reviews also note the need for long-term monitoring because effects on cardiovascular and cancer-related outcomes are not fully settled in all populations.
Medical Information Notice
This summary is for educational use only and is based on sources available at the time of review. It does not replace the official patient leaflet or individual assessment by a qualified healthcare professional.
Medical Sources
- U.S. FDA, Genotropin (somatropin) Prescribing Information — Official prescribing information
- Carter-Su C, Schwartz J, Smit LS. “Molecular mechanism of growth hormone action.” Annu Rev Physiol. 1996 — PubMed article
